Biotech Execs Promote Biomedical R&D At White House Meeting
Executive Summary
At meeting led by NIH Director Collins, participants talked about importance of biomedical research and need for partnerships between industry, government and academia.
You may also be interested in...
Scientists Marched To Protect NIH Grants, But Where Was Pharma?
Funding from the US National Institutes of Health is a vital source for biomedical research and pharmaceutical pipelines in turn – but biopharma companies have been largely silent on the matter.
NIH Funding Boost Underscores Tensions Between Trump, Congress
Onmibus funding bill would increase NIH funding by $2 billion, including $120 million increase for Precision Medicine Initiative; antibiotic resistance and Alzheimer's research also slated for increase.
Carrots and Stick: Biopharma At The White House
Drug industry executives discuss drug pricing and tax and regulatory reform in a high-profile meeting with President Trump at the White House.